MDR- and XDR-TB among suspected drug-resistant TB patients in a tertiary care hospital in India

Clinical Respiratory Journal

Volumn 5, Issue 1, 2011, Pages 19-25

  James, Prince ^a   Gupta, Richa ^a   Christopher, Devasahayam Jesudas ^a   Thankagunam, Balamugesh ^a   Veeraraghavan, Balaji ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Drug resistance; MDR TB; Tuberculosis; XDR TB

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MALE; PRIORITY JOURNAL; SMOKING; TERTIARY HEALTH CARE; TREATMENT DURATION; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HUMANS; INDIA; MALE; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 78650265320     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/j.1752-699X.2009.00184.x     Document Type: Article

References (12)

1. World Health Organization. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Antituberculosis Drug Resistance in the World. Report No. 4. WHO/ HTM/TB/2008.394. Geneva, WHO, 2008.
2. Shah NS, Wright A, Bai G-H, et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis. 2007;13: 380-7.
3. World Health Organization Report. Global Tuberculosis Control. Surveillance, Planning and Financing. Geneva, World Health Organization (WHO/HTM/TB/2007.376), 2007.
4. Chauhan LS. Drug resistant TB-RNTCP response. Indian J Tuberc. 2008;55: 5-8.
5. Ramachandran R, Nalini S, Chandrasekar V, et al. Surveillance of drug - resistant tuberculosis in the state of Gujrat, India. Int J Tuberc Lung Dis. 2009;13: 1154-60.
6. Almeida D, Rodrigues C, Udwadia ZF, et al. Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention. Clin Infect Dis. 2003;36: 152-4.
7. D'souza DTB, Mistry NF, Vira TS, et al. High levels of multidrug resistant tuberculosis in new and treatment failure patients from the revised national tuberculosis control programme in an urban metropolis (Mumbai) in Western India. BMC Public Health. 2009;9: 211.
8. World Health Organization. Guidelines for programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2008.402. Geneva, Switzerland: WHO; 2008.
9. Thomas A, Ramachandran R, Rehaman F, et al. Management of MDR-TB in the field: Tuberculosis Research Centre experience. Indian J Tuberc. 2007;54: 117-24.
10. Jain S, Rodrigues C, Mehta A, Udwadia ZF. High prevalence of XDR-TB from a tertiary care hospital in India. American Thoracic Society 2007 International Conference, San Francisco, CA, USA; May 2007. Abstract A510.
11. Mondal R, Jain A. Extensively drug-resistant Mycobacterium tuberculosis, India. Emerg Infect Dis. 2007;13: 1429-31.
12. Singh S, Sankar MM, Gopinath K. High rate of extensively drug-resistant tuberculosis in Indian AIDS patients. AIDS. 2007;21: 2345-7.